Yantai Zhenghai Biotechnology Co., Ltd. (SHE:300653)
China · Delayed Price · Currency is CNY 14.72
+0.11 (0.75%)
Aug 4, 2026, 3:04 PM CST
SHE:300653 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 347.75 | 364.14 | 363.23 | 413.65 | 433.22 | 400.18 |
Revenue Growth | -6.27% | 0.25% | -12.19% | -4.52% | 8.26% | 36.45% |
Gross Profit Gross Profit Growth | 300.81 | 312.71 | 318.34 | 370.67 | 383.35 | 355.75 |
Operating Income Operating Income Growth | 58.43 | 72.78 | 126.63 | 190.68 | 196.12 | 164.91 |
Net Income Net Income Growth | 70.53 | 82.41 | 134.64 | 190.96 | 185.44 | 168.55 |
Earnings Per Share EPS Growth | 0.39 | 0.46 | 0.75 | 1.06 | 1.28 | 0.94 |
EPS Growth | -42.58% | -38.67% | -29.24% | -17.19% | 36.17% | 42.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) Net Cash Growth | 650.99 | 637.1 | 622.27 | 675.19 | 616.7 | 571.67 |
Net Cash Growth | -1.51% | 2.38% | -7.84% | 9.48% | 7.88% | 28.52% |
Net Cash Per Share Net Cash Per Share Growth | 3.60 | 3.56 | 3.47 | 3.75 | 4.26 | 3.19 |
Cash & Investments Cash & Investments Growth | 650.99 | 637.1 | 622.27 | 675.19 | 616.7 | 571.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 71.02 | 97.19 | 151.38 | 180.48 | 187.84 | 166.13 |
Capital Expenditures CapEx Growth | -14.15 | -9.1 | -15.57 | -31.88 | -56.06 | -9.82 |
Free Cash Flow Free Cash Flow Growth | 56.87 | 88.09 | 135.81 | 148.6 | 131.78 | 156.31 |
Free Cash Flow Growth | -59.19% | -35.14% | -8.61% | 12.77% | -15.70% | 914.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 86.50% | 85.88% | 87.64% | 89.61% | 88.49% | 88.90% |
Operating Margin | 16.80% | 19.99% | 34.86% | 46.10% | 45.27% | 41.21% |
Pretax Margin | 21.30% | 24.20% | 41.95% | 52.80% | 48.96% | 47.87% |
Profit Margin | 20.28% | 22.63% | 37.07% | 46.16% | 42.80% | 42.12% |
FCF Margin | 16.35% | 24.19% | 37.39% | 35.92% | 30.42% | 39.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.280 | 0.280 | 0.460 | 0.802 | 0.600 | 0.587 |
Dividend Per Share Growth | -39.13% | -39.13% | -42.63% | 33.63% | 2.27% | 251.95% |
Dividend Yield | 1.92% | 1.43% | 2.25% | 2.98% | 1.53% | 1.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.75 | 43.05 | 28.21 | 27.36 | 41.74 | 47.54 |
Forward PE | 28.86 | 32.01 | 20.83 | 25.02 | 29.76 | 38.43 |
P/FCF Ratio | 45.98 | 40.27 | 27.97 | 35.15 | 58.74 | 51.26 |
PS Ratio | 7.52 | 9.74 | 10.46 | 12.63 | 17.87 | 20.02 |